Article Link: FDA Grants Accelerated Approval to Lartruvo (olaratumab) for Advanced Soft Tissue Sarcoma Source: FDA New Dru...
FDA Approves Genentech’s Cancer Immunotherapy Tecentriq (Atezolizumab) for People with a Specific Type of Metastatic Lung Cancer
Article Link: FDA Approves Genentech’s Cancer Immunotherapy Tecentriq (Atezolizumab) for People with a Specific Type of Metastatic Lung Cancer &...
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) Prefilled Syringe
Article Link: FDA Approves Genentech’s Lucentis (Ranibizumab Injection) Prefilled Syringe Source: FDA New Drug Approvals
FDA Approves Flublok Quadrivalent Influenza Vaccine
Article Link: FDA Approves Flublok Quadrivalent Influenza Vaccine Source: FDA New Drug Approvals
FDA Approves Carnexiv (carbamazepine) injection as Intravenous Short-Term Replacement Therapy for Certain Seizure Types
Article Link: FDA Approves Carnexiv (carbamazepine) injection as Intravenous Short-Term Replacement Therapy for Certain Seizure Types �...
FDA Approves Unique Low Dosage of Zubsolv
Article Link: FDA Approves Unique Low Dosage of Zubsolv Source: FDA New Drug Approvals
FDA Approves Orkambi (lumacaftor/ivacaftor) for Use in Children with Cystic Fibrosis Ages 6 through 11 who have Two Copies of the F508del Mutation
Article Link: FDA Approves Orkambi (lumacaftor/ivacaftor) for Use in Children with Cystic Fibrosis Ages 6 through 11 who have Two Copies of the F508de...
FDA Approves Stelara (ustekinumab) for Treatment of Adults with Moderately to Severely Active Crohn's Disease
Article Link: FDA Approves Stelara (ustekinumab) for Treatment of Adults with Moderately to Severely Active Crohn’s Disease ...
U.S. FDA Approves Labeling Update of Rexulti (brexpiprazole) for Maintenance Treatment of Schizophrenia
Article Link: U.S. FDA Approves Labeling Update of Rexulti (brexpiprazole) for Maintenance Treatment of Schizophrenia Sourc...
FDA Approves Expanded Indications for Ilaris (canakinumab) for Three Rare Periodic Fever Syndromes
Article Link: FDA Approves Expanded Indications for Ilaris (canakinumab) for Three Rare Periodic Fever Syndromes Source: FD...
